Related Experiment Video
Updated: Oct 10, 2025
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
244
Agomelatine: An Astounding Sui-generis Antidepressant?
Muhammad Naveed1,2, Lian-Di Li1, Gang Sheng2
1Department of Clinical Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing 211166, P.R. China.
Current Molecular Pharmacology
|December 10, 2021
Summary
Agomelatine, a melatonin analog, offers antidepressant and anxiolytic effects by targeting circadian rhythms and improving sleep. Its unique action on melatonin and serotonin receptors enhances mood and sleep patterns in patients with mood disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Major depressive disorder (MDD) is a leading cause of global disability and mortality.
- Current antidepressants have limitations, necessitating novel therapeutic approaches.
- Chronobiology and circadian rhythm disruptions are increasingly recognized in psychiatric disorders.
Purpose of the Study:
- To critically analyze the antidepressant properties of agomelatine.
- To evaluate agomelatine's safety, efficacy, and mechanism of action.
- To explore agomelatine's role in treating mood disorders, anxiety, and sleep disturbances.
Main Methods:
- Comprehensive literature search across PubMed, Scopus, Web of Science, Cochrane Library, Google Scholar, and PsycInfo.
- Keywords included agomelatine, melatonin analog, MDD, circadian rhythm, safety, efficacy, and related terms.
- Analysis of published articles on agomelatine's pharmacodynamics, pharmacokinetics, and clinical effects.
Main Results:
- Agomelatine acts as a melatonin receptor agonist (MT1/MT2) and a 5-HT2C receptor antagonist.
- It resynchronizes irregular circadian rhythms, improving sleep architecture.
- Clinical studies indicate antidepressant and anxiolytic efficacy with a favorable safety profile.
Conclusions:
- Agomelatine possesses unique antidepressant and anxiolytic properties.
- Its mechanism involves circadian rhythm regulation and sleep-wake cycle resynchronization.
- Agomelatine represents a novel therapeutic option for mood and anxiety disorders.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
416
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
416
01:25Antidepressant Drugs: Overview
872
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
872
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
272
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
272
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
723
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
723
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
483
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
483
01:21G-protein Coupled Receptors
124.2K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
124.2K